Stay updated on Lazertinib Combination in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Lazertinib Combination in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lazertinib Combination in NSCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The clinical trial record for the lazertinib and amivantamab study is now displayed, with information on its treatment arms, eligibility, measures, and locations. The page also includes study record dates, publications, and data-sharing details.
    Difference
    100%
    Check dated 2026-11-12T15:27:53.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-29T15:35:39.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    A site-wide NIH notice about website updates and the transition from “Artificial Intelligence” to “Super Intelligence” appears above the 403 error page.
    Difference
    1%
    Check dated 2026-10-22T15:48:06.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-15T15:43:43.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-08T16:11:28.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error page with a Home link, replacing the previous content and blocking access to the record details.
    Difference
    20%
    Check dated 2026-09-24T18:48:41.000Z thumbnail image

Stay in the know with updates to Lazertinib Combination in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lazertinib Combination in NSCLC Clinical Trial page.